MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $22,000 | -48.8% | 10,000 | -68.2% | 0.00% | -77.8% |
| Q2 2017 | $43,000 | -23.2% | 31,464 | 0.0% | 0.01% | -10.0% |
| Q1 2017 | $56,000 | -29.1% | 31,464 | -60.0% | 0.01% | -44.4% |
| Q4 2016 | $79,000 | -16.8% | 78,662 | +50.0% | 0.02% | -14.3% |
| Q3 2016 | $95,000 | +10.5% | 52,432 | +365.6% | 0.02% | -44.7% |
| Q4 2015 | $86,000 | – | 11,261 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |